Literature DB >> 19854564

Narrowing of the middle cerebral artery: artificial intelligence methods and comparison of transcranial color coded duplex sonography with conventional TCD.

Miroslaw Swiercz1, Maciej Swiat, Mikolaj Pawlak, John Weigele, Roman Tarasewicz, Andrzej Sobolewski, Robert W Hurst, Zenon D Mariak, Elias R Melhem, Jaroslaw Krejza.   

Abstract

The goal of the study was to compare performances of transcranial color-coded duplex sonography (TCCS) and transcranial Doppler sonography (TCD) in the diagnosis of the middle cerebral artery (MCA) narrowing in the same population of patients using statistical and nonstatistical intelligent models for data analysis. We prospectively collected data from 179 consecutive routine digital subtraction angiography (DSA) procedures performed in 111 patients (mean age 54.17+/-14.4 years; 59 women, 52 men) who underwent TCD and TCCS examinations simultaneously. Each patient was examined independently using both ultrasound techniques, 267 M1 segments of MCA were assessed and narrowings were classified as < or =50% and >50% lumen reduction. Diagnostic performance was estimated by two statistical and two artificial neural networks (ANN) classification methods. Separate models were constructed for the TCD and TCCS sonographic data, as well as for detection of "any narrowing" and "severe narrowing" of the MCA. Input for each classifier consisted of the peak-systolic, mean and end-diastolic velocities measured with each sonographic method; the output was MCA narrowing. Arterial narrowings less or equal 50% of lumen reduction were found in 55 and >50% narrowings in 26 out of 267 arteries, as indicated by DSA. In the category of "any narrowing" the rate of correct assignment by all models was 82% to 83% for TCCS and 79% to 81% for TCD. In the diagnosis of >50% narrowing the overall classification accuracy remained in the range of 89% to 90% for TCCS data and 90% to 91% for TCD data. For the diagnosis of any narrowing, the sensitivity of the TCCS was significantly higher than that of the TCD, while for diagnosis of >50% MCA narrowing, sensitivity of the TCCS was similar to sensitivity of the TCD. Our study showed that TCCS outperforms conventional TCD in detection of < or =50% MCA narrowing, whereas no significant difference in accuracy between both methods was found in the diagnosis of >50% MCA narrowing. (E-mail: jaroslaw.krejza@uphs.upenn.edu).

Entities:  

Mesh:

Year:  2010        PMID: 19854564     DOI: 10.1016/j.ultrasmedbio.2009.05.005

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  5 in total

1.  Surface Point Cloud Ultrasound with Transcranial Doppler: Coregistration of Surface Point Cloud Ultrasound with Magnetic Resonance Angiography for Improved Reproducibility, Visualization, and Navigation in Transcranial Doppler Ultrasound.

Authors:  J N Stember; K L Terilli; E Perez; M Megjhani; C A Cooper; S Jambawalikar; S Park
Journal:  J Digit Imaging       Date:  2020-08       Impact factor: 4.056

2.  A Case Report of Thunderclap Headache with Sub-arachnoid Hemorrhage and Negative Angiography: A Review of Call-Fleming Syndrome and the use of Transcranial Dopplers in Predicting Morbidity.

Authors:  Brennen Bittel; Kathrin Husmann
Journal:  J Vasc Interv Neurol       Date:  2011-07

3.  ABCD² score may discriminate minor stroke from TIA on patient admission.

Authors:  Hui Zhao; Qingjie Li; Mengru Lu; Yuan Shao; Jingwei Li; Yun Xu
Journal:  Transl Stroke Res       Date:  2013-10-17       Impact factor: 6.829

4.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

Review 5.  Research progress in ultrasound use for the diagnosis and treatment of cerebrovascular diseases.

Authors:  Li Yan; Xiaodong Zhou; Yu Zheng; Wen Luo; Junle Yang; Yin Zhou; Yang He
Journal:  Clinics (Sao Paulo)       Date:  2019-03-07       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.